The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

When Rohan Mirchandani, CEO of Epigamia, died from sudden cardiac arrest at a young age of 42, it highlighted once again the ...

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with ...

With new data from several studies this year, researchers are chipping away at the question of when to revascularize and how.

Costs related to cardiovascular health care represent a high burden and have been trending upward the past several years in the United States.

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk, according to a review published online Nov. 21 ...

FastWave Medical's technology delivers energy pulses to break up plaque in arteries caused by coronary artery disease and ...

Researchers have identified that vericiguat, a new drug for heart failure, is safe in patients with coronary artery disease.

The researchers hope the breakthrough will help scientists cure a genetic disorder that increases the likelihood of dying from coronary artery disease at a young age.

A new study published in the Journal of the American College of Cardiology illuminate the critical relationship between ...